Filter News
Area of Research
- (-) Neutron Science (21)
- (-) Transportation Systems (1)
- Advanced Manufacturing (10)
- Biological Systems (1)
- Biology and Environment (10)
- Clean Energy (58)
- Computer Science (1)
- Fusion and Fission (4)
- Fusion Energy (7)
- Isotopes (4)
- Materials (47)
- Materials for Computing (5)
- National Security (8)
- Nuclear Science and Technology (28)
- Nuclear Systems Modeling, Simulation and Validation (1)
- Quantum information Science (3)
- Supercomputing (24)
News Topics
- (-) 3-D Printing/Advanced Manufacturing (2)
- (-) Biomedical (7)
- (-) Nanotechnology (5)
- (-) Nuclear Energy (2)
- (-) Physics (4)
- (-) Security (1)
- (-) Transportation (2)
- Advanced Reactors (1)
- Artificial Intelligence (1)
- Big Data (1)
- Bioenergy (4)
- Clean Water (1)
- Climate Change (1)
- Computer Science (8)
- Coronavirus (5)
- Energy Storage (3)
- Environment (6)
- Machine Learning (2)
- Materials Science (11)
- Mathematics (1)
- Microscopy (2)
- National Security (1)
- Neutron Science (43)
- Polymers (1)
- Quantum Science (4)
- Summit (5)
- Sustainable Energy (1)
Media Contacts
OAK RIDGE, Tenn., March 20, 2019—Direct observations of the structure and catalytic mechanism of a prototypical kinase enzyme—protein kinase A or PKA—will provide researchers and drug developers with significantly enhanced abilities to understand and treat fatal diseases and neurological disorders such as cancer, diabetes, and cystic fibrosis.
As the rise of antibiotic-resistant bacteria known as superbugs threatens public health, Oak Ridge National Laboratory’s Shuo Qian and Veerendra Sharma from the Bhaba Atomic Research Centre in India are using neutron scattering to study how an antibacterial peptide interacts with and fights harmful bacteria.